GLPwatch

Rybelsus for Anxiety

semaglutide · Investigational / off-label

Last updated 2026-05-28 15:46 UTC

Rybelsus (semaglutide) is not FDA-approved for treating anxiety, and any use for this condition is off-label or investigational. Research includes mixed findings, such as animal studies suggesting potential anxiolytic effects and human data primarily focused on adverse event reporting or psychiatric safety in other contexts.

AI summary of the sources below.

DrugRybelsus (semaglutide)
ConditionAnxiety
Approval statusInvestigational / off-label
Research papers13

Rybelsus is not FDA-approved for anxiety; the research below reflects investigational or off-label study only.

Research on semaglutide for anxiety (13)

Search PubMed ↗